Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06452810 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area

A NA study of Skin Health, sponsored by Sahajan.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT06452810: Completed NA study of Skin Health, sponsored by Sahajan.

NCT06452810 is a NA study of Skin Health that has completed, run by Sahajan. The registered enrollment target is 35 participants, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06452810, a NA study of Skin Health, has completed, sponsored by Sahajan.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

This virtual single-group clinical trial aims to evaluate the effects of the Sahajan Golden Glow Balm on the health and appearance of the skin in the periorbital area over a period of 6 weeks. Participants will apply the product twice daily and complete questionnaires at various intervals. Photos for expert skin grading will be taken at Baseline and Week 6.

Primary Outcome

The primary outcome measure will assess changes in the health and appearance of the skin in the periorbital area, evaluated via expert skin grading by a board-certified dermatologist.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Experimental: Sahajan Golden Glow Balm

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2024-02-29
Est. Completion 2024-05-03
Phase NA
Sahajan

1 total trials

What the finished NCT06452810 record still lists

NCT06452810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (33% lower).

The record links to 1 condition, with Skin Health appearing as the primary indexed condition, and to 1 intervention - of which Experimental: Sahajan Golden Glow Balm is the first listed.

NCT06452810 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06452810 about?

NCT06452810 is a clinical study titled "A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area". This virtual single-group clinical trial aims to evaluate the effects of the Sahajan Golden Glow Balm on the health and appearance of the skin in the periorbital area over a period of 6 weeks. Participants will apply the product twice daily and complete questionnaires at various intervals. Photos fo...

What is the current status of trial NCT06452810?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2024-02-29. Estimated completion is 2024-05-03.

What conditions does trial NCT06452810 study?

This clinical trial studies the following conditions: Skin Health.

What interventions are being tested in trial NCT06452810?

The interventions under investigation include: Experimental: Sahajan Golden Glow Balm (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06452810?

This trial is sponsored by Sahajan, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06452810 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06452810, the US trial registry maintained by the National Library of Medicine. NCT06452810 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.